Lipid profile Total cholesterol, TG, high-density lipoprotein (HDL), and LDL were measured using a semi-auto chemistry analyzer (Cobas c111, Roche Diagnostics, Switzerland)
When recorded at 48 weeks, least-squares mean percentage change of body weight was -8.7% in the retatrutide 1-mg group, -17.1% in the combined 4-mg group, -22.8% in the combined 8-mg group, -24.2% in the 12-mg group, and -2.1% in the placebo group
doi:10.1515/jbcpp-2020-0099
Bicarnesine 24
Researchers looked at breast milk from eight women taking weekly semaglutide injections and found no detectable semaglutide in any of the milk samples
Focus: GLP-1 receptor agonists, semaglutide, and diabetic eye disease Goal: Help patients and families understand benefits, risks, and when retinal monitoring matters most Evidence-Based: Preferred Practice Patterns Standards of Care Systematic Reviews Meta-Analyses Diabetic Eye Disease Knowledge Hub Start with the complete guide: Diabetic Eye Disease: The Complete Patient Guide Quick Navigation What Are GLP-1 Drugs